Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and deliver clinical imaging studies. Applied with our extensive experience and expertise in drug development and disease biology, our tailored solutions have helped our customers to solve complex problems to empower confident decision-making at every stage of clinical drug development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.
* magnetic resonance imaging
**positron emission tomography
Nordic Bioscience has more than 25 years’ experience in biomarker development and integrating these biomarkers into clinical trials with extensive scientific expertise in the fields of fibrosis, rheumatology, immunology and oncology.
Using our unique biomarker technology, we identify predictive and prognostic biomarkers which are used to enrich clinical trials and may reduce trial length and size required to determine therapeutic efficacy.
With over 500 publications in leading journals, we pride ourselves with our highly scientific approach and mindset.